ZARVY

Plaquenil 200mg is an original branded medication from Sanofi containing Hydroxychloroquine 200mg, trusted for the treatment of autoimmune diseases and malaria prevention. It is widely prescribed for rheumatoid arthritis and lupus erythematosus due to its immune-modulating and anti-inflammatory properties. In addition, it has long been used against malaria, targeting the parasite’s ability to digest hemoglobin. While COVID-19 was once investigated as an off-label indication, its role remains controversial and is not recommended by major health authorities.

ZY-Q 200 is a generic medication manufactured by Zydus Cadila, containing Hydroxychloroquine 200mg as its active ingredient. It is widely available through an online pharmacy for the treatment and prevention of malaria, as well as in managing autoimmune conditions like lupus and rheumatoid arthritis. Hydroxychloroquine interferes with the lifecycle of malaria parasites within red blood cells, making it an essential tool in malaria prophylaxis and treatment. Beyond its antiparasitic properties, ZY-Q 200 is an effective immunomodulator, reducing inflammation and controlling overactive immune responses in autoimmune disorders, often compared with corticosteroids such as Omnacortil. Recently, Hydroxychloroquine has been studied for its potential off-label use in managing COVID-19. Its antiviral and anti-inflammatory properties have been explored for reducing respiratory inflammation and mitigating severe symptoms. In dermatology, it is sometimes discussed alongside treatments like Azelaic Acid, Tretinoin Cream, and Acne Treatment approaches, given its immune-modulating effects. However, its role in COVID-19 treatment remains controversial and under clinical investigation.

HQTOR 200 is a generic medication manufactured by Torrent Pharmaceuticals Ltd, featuring hydroxychloroquine (200mg) as its active ingredient. This versatile medication is widely used in the prevention and treatment of malaria and in managing autoimmune diseases like lupus and rheumatoid arthritis. Hydroxychloroquine operates by disrupting the lifecycle of malaria parasites within red blood cells, effectively controlling and preventing the spread of infection. In the realm of autoimmune conditions, it functions as an immunomodulator, reducing inflammation and alleviating symptoms of disorders such as rheumatoid arthritis. HQTOR 200 has also gained attention for its off-label use in COVID-19 management. Clinical studies have explored its potential in reducing inflammation and mitigating severe respiratory symptoms associated with the virus, making it a subject of significant interest during the pandemic.

HETQ 200 is a generic medication manufactured by Hetero Healthcare Pvt Ltd, containing hydroxychloroquine (200mg) as its active ingredient. This widely used medication is recognized for its role in treating and preventing malaria and managing autoimmune diseases like lupus and rheumatoid arthritis. Hydroxychloroquine disrupts the lifecycle of malaria parasites within red blood cells, effectively preventing the spread and growth of the infection. Beyond its antiparasitic properties, it serves as a potent immunomodulator, providing relief for autoimmune conditions by controlling excessive immune activity and reducing inflammation. HETQ 200 has also been explored for its off-label use in the treatment of COVID-19. Its antiviral and anti-inflammatory effects have been studied as a potential means of alleviating severe respiratory symptoms and reducing inflammation, although its use for this purpose remains under investigation and varies by region.

HCQS 200 mg (Hydroxychloroquine sulfate 200 mg) — manufactured by IPCA Laboratories Ltd — is an oral immunomodulatory and antimalarial agent indicated for chronic autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus) and for prevention/treatment of certain forms of malaria. HCQS modulates antigen presentation and cytokine activity and impairs aspects of the malaria parasite lifecycle, producing anti-inflammatory and antiparasitic effects. Use only under medical supervision; available from licensed pharmacies and reputable online pharmacy services with a valid prescription.

SIGNAQUIN 200 is a generic medication manufactured by Signature Pharmaceuticals Pvt Ltd, containing hydroxychloroquine 200mg as its active ingredient. Classified under Antiparasitics and Antibiotics & Infections, it is widely used for managing malaria and autoimmune conditions. Hydroxychloroquine is primarily recognized for preventing and treating malaria by disrupting the lifecycle of the parasite within red blood cells. Additionally, it is effective in managing autoimmune diseases such as lupus and rheumatoid arthritis by modulating immune responses. In recent years, hydroxychloroquine has been investigated as an alternative treatment for COVID-19, due to its anti-inflammatory and antiviral properties. While not universally approved, its potential to mitigate respiratory inflammation and improve patient outcomes has been explored in clinical settings.